NCT06139952CompletedPhase 4
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
Assessment of the Effect of Atorvastatin and N-acetyl Cysteine on Prevention of Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography CIN
Source: ClinicalTrials.gov · Last updated 11 Jul 2024
Brief summary (registry, in English)
Given the limited understanding of the impact of statin and N-acetyl cysteine use before angiography in preventing contrast-induced nephropathy (CIN), the objective of this study is to evaluate the effectiveness of atorvastatin in preventing CIN among patients undergoing coronary angiography.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- First submitted
- 15 Nov 2023
- Start date
- 1 Dec 2023
- Primary completion date
- 1 Mar 2024
- Lead sponsor
- Ain Shams University
- Diseases
- Coronary artery disease
- NCT number
- NCT06139952
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 120
- From 1 Dec 2023 to the primary completion date, 1 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior exposure to contrast media within 7 days
Other illness
- Patients undergoing emergency primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Lab values
- Patients with Serum creatinine conc of \>2.1 mg/Dl
Other
- Pregnant or lactating women
- Contraindication for a high-dose statin, N-acetyl Cysteine prescription
Who the study is looking for
- Undergoing elective Coronary angiography who will receive coronary angiography contrast media.
- Must have at least two consecutive serum creatinine measurements (Before and after Contrast exposure)
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Cardiovascular Hospital Coordinator of this site? Confirm its status | Heliopolis | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.